Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine plus R-GDP for interim PET-positive newly diagnosed DLBCL
ChiCTR2000028858Phase 2Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of decitabine in diffuse large B-cell lymphoma (DLBCL), sponsored by Union Hospital. Primary endpoints: Complete response, Partial response and 3 more. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
decitabine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on ChiCTR2000028858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028858.